NCT03985605View on ClinicalTrials.gov

Therapeutic Drug Monitoring of Antiinfectives for Patients With Severe Illness = TAPSI

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Infection, Bacterial
Trial Locations (1)

81377

Department of Anaesthesiology of the University Hospital of Munich, Munich

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER

NCT03985605 - Therapeutic Drug Monitoring of Antiinfectives for Patients With Severe Illness = TAPSI | Biotech Hunter | Biotech Hunter